Jeena Sikho Lifecare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Publication of Research Articles.'.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare Limited has informed the exchanges about the publication of six research articles in the European Journal of Pharmaceutical and Medical Research (Vol 12, Issue 8, 2025). The articles are co-authored by the company's Managing Director Acharya Manish Grover along with ten other Ayurvedic doctors and consultants. The case studies cover Ayurvedic management of adenomyosis, chronic liver disease with type 2 diabetes, polycystic kidney disease, infertility, uterine fibroid, and Prameha. The company says this highlights its commitment to evidence-based Ayurvedic research and clinical practices.
This is a corporate disclosure about research publications and does not directly impact revenue, orders, or financials. For shareholders, it signals the company's effort to build clinical credibility for its Ayurvedic treatments, which could support brand positioning but does not change near-term business outlook.